Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Cancer

Dan Koboldt blogs about WashU's recent kickoff party for its Cancer Genomics Initiative. The center's goal is to sequence 150 cancer genomes in one year. They'll be looking at AML some more — they published on AML genomes in Nature last fall and this month in the New England Journal of Medicine — as well as breast cancer, lung cancer, glioblastoma multiforme, and ovarian cancer. Koboldt adds that he's heard rumors that they'll also tackle rarer cancers such as multiple myeloma. "As Tim Ley said yesterday, it's thrilling to be a part of this. We truly are entering the golden age of cancer genomics," Koboldt blogs.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.